Patients were randomized into two groups, ESP and control. Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level was performed preoperatively to all patients in the ESP group. The control group received no intervention. Patients in both groups were provided with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
42
Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine ( Marcaine ) at the T4 vertebral level will be performed.
Postoperative 0.5 mg/kg morphine and 1 gr paracetamol will be admistered intravenously in the operation theatre and intravenous patient controlled analgesia (PCA) will be performed in the plastic surgery ward postoperatively
Kocaeli Unıversity
Kocaeli, izmit, Turkey (Türkiye)
Total opioid consumption
Patients in both groups will receive opioid in postoperative period. Total opioid consumption in miligrams will be compared
Time frame: Postoperative total opioid consumption in miligrams will be recorded at hour 24
Intraoperative opioid consumption
The amount of remifentanyl administered to patients via intravenous infusion during the operation in micrograms, will be recorded.
Time frame: At the end of the operation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.